Sharma Ameya, Puri Vivek, Kumar Pradeep, Singh Inderbir
Chitkara College of Pharmacy, Chitkara University, Punjab 140401, India.
Chitkara University School of Pharmacy, Chitkara University, Himachal Pradesh 174103, India.
Membranes (Basel). 2020 Dec 23;11(1):7. doi: 10.3390/membranes11010007.
The various biological and molecular cascades including different stages or phases such as inflammation, tissue proliferation, and remodeling phases, which significantly define the wound healing process. The natural matrix system is suggested to increase and sustain these cascades. Biocompatible biopolymers, sodium alginate and gelatin, and a drug (Rifampicin) were used for the preparation of fibers into a physical crosslinking solution using extrusion-gelation. The formed fibers were then loaded in transdermal films for wound healing applications. Rifampicin, an antibiotic, antibacterial agent was incorporated into fibers and afterwards the fibers were loaded into transdermal films. Initially, rifampicin fibers were developed using biopolymers including alginate and gelatin, and were further loaded into polymeric matrix which led to the formation of transdermal films. The transdermal films were coded as TF1, TF2, TF3 and TF4.The characterization technique, FTIR, was used to describe molecular transitions within fibers, transdermal films, and was further corroborated using SEM and XRD. In mechanical properties, the parameters, such as tensile strength and elongation-at-break (extensibility), were found to be ranged between 2.32 ± 0.45 N/mm to 14.32 ± 0.98 N/mm and 15.2% ± 0.98% to 30.54% ± 1.08%. The morphological analysis firmed the development of fibers and fiber-loaded transdermal films. Additionally, physical evaluation such as water uptake study, water transmission rate, swelling index, moisture content, and moisture uptake study were executed to describe comparative interpretation of the formulations developed. In vivo studies were executed using a full thickness cutaneous wound healing model, the transdermal films developed showed higher degree of contraction, i.e., 98.85% ± 4.04% as compared to marketed formulation (Povidone). The fiber-in-film is a promising delivery system for loading therapeutic agents for effective wound care management.
各种生物和分子级联反应包括不同阶段或时期,如炎症、组织增殖和重塑阶段,这些阶段显著地定义了伤口愈合过程。天然基质系统被认为可以增强和维持这些级联反应。生物相容性生物聚合物海藻酸钠和明胶以及一种药物(利福平)被用于通过挤出 - 凝胶化法将纤维制备到物理交联溶液中。然后将形成的纤维加载到用于伤口愈合应用的透皮膜中。利福平是一种抗生素、抗菌剂,被掺入纤维中,之后纤维被加载到透皮膜中。最初,使用包括海藻酸盐和明胶的生物聚合物开发了利福平纤维,并进一步加载到聚合物基质中,从而形成了透皮膜。透皮膜被编码为TF1、TF2、TF3和TF4。表征技术傅里叶变换红外光谱(FTIR)被用于描述纤维、透皮膜内的分子转变,并通过扫描电子显微镜(SEM)和X射线衍射(XRD)进一步证实。在机械性能方面,诸如拉伸强度和断裂伸长率(延伸性)等参数被发现介于2.32±0.45 N/mm至14.32±0.98 N/mm以及15.2%±0.98%至30.54%±1.08%之间。形态分析证实了纤维和载有纤维的透皮膜的形成。此外,还进行了诸如吸水性研究、水传输速率、溶胀指数、水分含量和吸湿研究等物理评估,以描述所开发制剂的比较解释。使用全层皮肤伤口愈合模型进行了体内研究,所开发的透皮膜显示出比市售制剂(聚维酮)更高的收缩程度,即98.85%±4.04%。膜内纤维是一种有前景的给药系统,可用于加载治疗剂以进行有效的伤口护理管理。